Abstract
The pathophysiological mechanism involved in side effects of radiation therapy and especially the role of the endothelium remains unclear. Previous results showed that plasminogen activator inhibitor-type 1 (PAI-1) contributes to radiation-induced intestinal injury and suggested that this role could be driven by an endothelium-dependent mechanism. We investigated whether endothelial-specific PAI-1 deletion could affect radiation-induced intestinal injury. We created a mouse model with a specific deletion of PAI-1 in the endothelium (PAI-1KOendo) by a Cre-LoxP system. In a model of radiation enteropathy, survival and intestinal radiation injury were followed as well as intestinal gene transcriptional profile and inflammatory cells intestinal infiltration. Irradiated PAI-1KOendo mice exhibited increased survival, reduced acute enteritis severity and attenuated late fibrosis compared with irradiated PAI-1flx/flx mice. Double E-cadherin/TUNEL labeling confirmed a reduced epithelial cell apoptosis in irradiated PAI-1KOendo. High-throughput gene expression combined with bioinformatic analyses revealed a putative involvement of macrophages. We observed a decrease in CD68+cells in irradiated intestinal tissues from PAI-1KOendo mice as well as modifications associated with M1/M2 polarization. This work shows that PAI-1 plays a role in radiation-induced intestinal injury by an endothelium-dependent mechanism and demonstrates in vivo that the endothelium is directly involved in the progression of radiation-induced enteritis.
Similar content being viewed by others
Introduction
Used for more than half of patients with tumors, radiotherapy plays a crucial role in cancer cure. The therapeutic index of radiotherapy depends on two parameters, tumor control and normal tissue tolerance. Despite huge advances in the planning of dose distribution to the target volume, toxicity of surrounding healthy tissues remains the most important radiation dose-limiting factor1. Tumors in the abdominal cavity and pelvis account for more than half of radiation treatments and in recent years the notion has emerged of “pelvic radiation disease”, which covers all symptoms associated with healthy tissue toxicity, from acute complications to chronic and fibrotic damage, the latter affecting 10% of patients2. Often underestimated, radiation enteropathy is a real clinical problem and long-term prevalence exceeds that of inflammatory bowel disease3. If we want to identify relevant therapeutic approaches, the crucial scientific challenge is to improve our knowledge of the pathophysiological mechanisms involved in the progression of radiation enteropathy.
Tissue response to radiation has long been explained by the target cell concept4. Concerning radiation enteropathy, the severity of epithelial depletion has long been considered as the sole determinant of acute intestinal injury. The contemporary view involves several cell types and molecular mechanisms, which together form an orchestrated response and contribute to the initiation, progression and chronicity of radiation-induced injury3. The concept that the microvasculature plays a central role in the radiation toxicity of many tissues, including the intestine5, is often described, but lacks robust demonstration. Irradiation leads to endothelial cell apoptosis, increased vascular permeability and acquisition of a pro-inflammatory and pro-coagulant phenotype. These modifications strongly participate in the development of radiation-induced damage, notably in the bowel6. We have used tissue-specific knockout models to study the role of the endothelial compartment in the progression of radiation-induced intestinal injury. We hypothesized that the pool of plasminogen activator inhibitor-type 1 (PAI-1) produced by endothelial cells could be involved in the development and progression of radiation-induced intestinal damage. PAI-1 belongs to the family of serine protease inhibitors and is the main inhibitor of plasminogen to plasmin conversion via inhibition of its targets uPA and tPA7. Consequently, PAI-1 limits fibrin degradation and plasmin-dependent matrix metalloproteinase activation. PAI-1 is produced by several cell types in pathological conditions and is involved in many pathophysiological processes, including inflammation8, fibrosis9,10 and macrophage adhesion/migration11. So far, it has been shown that PAI-1 is overexpressed in the endothelial cells of different irradiated healthy tissues in patients12,13. Moreover, PAI-1 genetic deficiency in mice limits the severity of radiation-induced intestinal injury13 and improves skin wound healing after irradiation14. There is a body of evidence to connect PAI-1 to the endothelial response to radiation and the severity of radiation-induced damage, although this link has not been demonstrated. In the present work, we investigated whether specific PAI-1 deletion in the endothelium affects the intestinal response to radiation exposure and show that the endothelium is directly involved in the progression of radiation-induced enteritis.
Results
Endothelial PAI-1 deletion protects mice against acute radiation-induced intestinal injury
In order to study the consequences of genetic inactivation of PAI-1 in endothelial cells, we generated PAI-1 floxed mice (Fig. 1 and Supplementary Fig. 1a,b) and crossed them with VECad-Cre mice to produce endothelial-specific PAI-1 knockout mice (Supplementary Fig. 2). The specificity of endothelium recombination events in intestinal tissue was checked using ROSA26 reporter mice crossed with VECad-Cre or VECad-Crei mice (Supplementary Fig. 3 and 4) and a genotyping strategy was used to genotype the mice and to detect the excised allele (Supplementary Fig. 1c). We observed decreased expression of PAI-1 mRNA in lung and gut in PAI-1KOendo mice compared with PAI-1flx/flx mice (Supplementary Fig. 1d). We observed no differences in PAI-1 mRNA level between PAI-1flx/flx mice and C57BL/6J mice (Supplementary Fig. 1e) showing that Loxp sites insertion has no effects on PAI-1 basal level expression. In a model of radiation enteropathy, intestinal PAI-1 expression increased from 5 h to up to 6 weeks post-exposure, while endothelial PAI-1 deletion partially limited this radiation-induced PAI-1 up-regulation (Fig. 2a). We monitored survival and observed that genetic PAI-1 deletion in endothelium protects mice from death after a high dose of ionizing radiation localized to a small part of the gut (Fig. 2b). More than 60% of irradiated PAI-1flx/flx mice died within two weeks (P = 0.0014 versus sham-IR PAI-1flx/flx mice), whereas about 75% of PAI-1KOendo mice survived (P = 0.084 versus sham-IR PAI-1flx/flx mice and p = 0.014 versus irradiated PAI-1flx/flx mice). We examined intestinal tissue injury in depth 3 and 7 days after irradiation (Fig. 3). Mucosal injury was reduced in irradiated PAI-1KOendo mice compared with irradiated PAI-1flx/flx mice (Fig. 3a–c), with a better index of cryptic damage at day 3 (Fig. 3b) and signs of a mucosal regeneration and reduced muscle inflammation at day 7 after irradiation (Fig. 3d,e).
Radiation-induced epithelial cell death is reduced in PAI-1KOendo mice
To explain the differences we observed in the acute phase, we plotted a molecular expression profile 5 h after irradiation. The mRNA levels of 106 genes were measured by real-time PCR using a TaqMan low-density array (TLDA) complemented with a panel of 12 individual genes. Biological information was extracted using both statistical and bioinformatic tools. Hierarchical clustering analyses discriminated sham-IR from irradiated mice (Supplementary Fig. 5a). Statistical analyses revealed a specific molecular signature of radiation exposure according to the expression or not of PAI-1 in the endothelium. This molecular signature is shown in Fig. 4a and Supplementary Fig. 5b–e. We detected similar decreased expression of BIRC5 and increased expression of Bax in both irradiated PAI-1KOendo and PAI-1flx/flx mice (Supplementary Fig. 5f). However, up-regulation of BBC3, a gene that has been implicated in radiation-induced intestinal injury15, was only observed in irradiated PAI-1flx/flx mice, suggesting differences in apoptosis-related effects in the 2 mouse lineages. Double labeling of epithelial cells and TUNEL-positive cells revealed that epithelial cell apoptosis in intestinal crypts was significantly increased in irradiated mice 5 h and 24 h after irradiation, whatever the status of PAI-1. However, the level of apoptotic cells was reduced in irradiated PAI-1KOendo mice compared with irradiated PAI-1flx/flx mice (Fig. 4c,d).
Constitutive and inducible endothelial PAI-1 deletions protect mice from late radiation-induced intestinal injury
As described by Zheng et al.16, the model of localized intestinal radiation injury offers the opportunity to study the progression of damage over several weeks. Six weeks after irradiation, we observed patches of intestinal fibrosis, as shown in a previous study by our team13. Sirius red staining revealed that collagen deposition is reduced in irradiated PAI-1KOendo mice compared with irradiated PAI-1flx/flx mice, as reflected by the fibrosis score (Fig. 5a,b). To confirm these results we also used an inducible knockout model using VECad-creERT2 mice. We observed a reduced radiation-induced fibrosis score in PAI-1KOendo(i) mice compared with PAI-1flx/flx mice treated with tamoxifen (Fig. 5c).
Endothelial PAI-1 deletion impacts the intestinal gene expression profile following radiation exposure
Because PAI-1 has anti-fibrinolytic properties, we hypothesized that reduced acute and late intestinal injury in PAI-1KOendo mice could be due to differences concerning fibrinolysis. We observed acute and chronic fibrin deposition in irradiated animals, but no differences between the 2 genotypes were noted (Supplementary Fig. 6), suggesting that the differences between the mouse lineages did not depend on fibrinolysis. Since the difference between the 2 lineages could be explained by a difference in the immune response, we next investigated the immune gene expression profile at day 3 and day 7 after irradiation by RT-qPCR using a TLDA methodology complemented with individual qPCR (Supplementary Figs 7 to 10). As for the 5-h time-point, hierarchical clustering analyses put sham-IR and irradiated mice into 2 different clusters, while the 2 mouse lineages PAI-1flx/flx and PAI-1KOendo could not be differentiated by this unsupervised statistical analysis tool (Fig. 6a–c and Supplementary Figs 7a and 9a). In-depth analyses of these results using supervised statistics and bioinformatic tools revealed differences between irradiated PAI-1flx/flx and PAI-1KOendo mice at both 3 and 7 days after irradiation (Fig. 6b–d). Volcano plots identified a specific radiation signature according to PAI-1 status in the endothelium (Supplementary Fig. 7b,c and Supplementary Fig. 9b,c). Bioinformatic tools were then used to establish whether a particular biological function could explain the protection of PAI-1KOendo mice from radiation-induced damage (Supplementary Fig. 8 and 10 and Supplementary Table 1). Interestingly, gene ontology enrichment analyses revealed clear differences between PAI-1flx/flx and PAI-1KOendo mice following radiation exposure (Supplementary Table 2). According to the total number of entities in each enrichment result, the “response to hypoxia” Gene Ontology (GO) term was ranked first in the irradiated PAI-1 KOendo mouse group, but was not ranked in the irradiated PAI-1flx/flx mouse group. These results led us to examine whether PAI-1 up-regulation could be driven by a hypoxia-dependent molecular mechanism. We therefore generated mice with a specific genetic hypoxia inducible factor-1α (HIF-1α) deletion in endothelial cells (VECad-Cre+/−/HIF-1αflx/flx), allowing us to show that intestinal PAI-1 overexpression after local intestine irradiation is at least partly dependent on HIF-1α expression in the endothelium (Supplementary Fig. 11). We detected overexpression at 3 and 7 days of several molecules involved in the positive chemotaxis of both neutrophils and monocytes (CCL2, TNF, VEGFA, IL6, CCL3) (Fig. 6 and Supplementary Table 1), indicating that this process could be important in the observed phenomenon. Myeloperoxidase (MPO) labeling showed no differences between irradiated mice, whatever the status of PAI-1 in the endothelium (Supplementary Fig. 12). Moreover, we observed that TNFα overexpression was higher in irradiated PAI-1flx/flx mice (fold change of 17.4) than in irradiated PAI-1KOendo mice (fold change of 6.9) at day 7 post-exposure, compared with sham-IR mice (Supplementary Table 1). On the other hand, 3 days after irradiation, the macrophage marker CD68 gene was only overexpressed in PAI-1flx/flx mice. Seven days after irradiation, CD68 overexpression was almost two times higher in irradiated PAI-1flx/flx mice than in irradiated PAI-1KOendo mice (fold changes of respectively 8.7 and 4.9) (Supplementary Table 1). Altogether, these results suggest that PAI-1 deletion in endothelium affected radiation-induced macrophage infiltration.
Conditional endothelium-specific PAI-1 deletion limits macrophage infiltration and influences macrophage M1/M2 polarization
We monitored macrophage infiltration and polarization during the progression of radiation enteropathy. Seven days after irradiation, immunolabeling experiments showed a decrease of CD68+ cells in irradiated PAI-1KOendo mice compared with irradiated PAI-1flx/flx mice (Fig. 7a,b). A slight decrease of CD68+ cells was also observed at 3 days, but there were no differences after 6 weeks (Supplementary Fig. 13). Because macrophage polarization is a crucial process involved in wound healing, we next monitored macrophage polarization using CD68/iNOS and CD68/CD206 double immunolabeling to quantify the levels of M1 and M2 macrophage polarization (Fig. 7c,e). The number of M1 macrophages increased following radiation exposure, at 3, 7 and up to 42 days after irradiation (Fig. 7d). However, the increased level of M1 cells was reduced in irradiated mice with endothelial PAI-1 genetic deletion. For M2 polarization, we observed at 3 days an increased level of CD68/CD206+ cells in irradiated PAI-1flx/flx mice, but not in PAI-1KOendo mice (Fig. 7f). While no statistical difference was noted at day 7 between the 2 mouse strains, we observed that the level of M2 macrophages was higher in PAI-1KOendo mice than in PAI-1flx/flx mice 6 weeks after irradiation (Fig. 7f).
Discussion
This work strengthens the concept that endothelium strongly contributes to the progression of radiation-induced intestinal injury. Using a new model of transgenic mice specifically knocked-out for PAI-1 in endothelial cells, we demonstrate that this protein orchestrates the progression of enteritis by an endothelium-dependent mechanism.
Endothelium has already been described as a crucial compartment involved in gastrointestinal syndrome (GIS)17,18,19 in studies that used total body or abdominal irradiation. However, conflicting results obtained with intravascular boronated liposome have challenged this concept20,21 and the role of endothelium in normal tissue radiation injury need to be cleared. Unlike GIS models, the model of radiation enteropathy that we used allows exploration of the progression of enteritis and radiation-induced late effects. Aware that a single dose of 19 Gy is not representative of or comparable to the conventional fractionation scheme used in clinical practice, this preclinical model is nonetheless useful in providing proof of principle that a specific molecular target in a specific compartment may be associated with radiation injury. Moreover, the tendency of radiation therapy practice to move toward high doses per fraction, such as in stereotactic body radiation therapy for prostate cancer, raises the question of potentially enhanced injury to organs at risk22. Clearly, this preclinical model could help to address some scientific issues in this context.
Advances in genetic engineering provide a powerful model system to study the mechanisms of normal tissue injury after irradiation23. In this way, using the Cre-loxP system to delete p53, it was shown that p53 functioned in endothelial cells to protect mice from myocardial injury after whole-heart irradiation24. Moreover, using Villin–Cre mice, one study demonstrated that p53 is required in epithelial cells to prevent GIS25. We previously showed that PAI-1 total knockout mice are protected against radiation enteritis, but there was no evidence that this was dependent on the PAI-1 endothelial pool13. We therefore created PAI-1 floxed mice to answer this question and we present here the first report using this transgenic model. To our knowledge, ours is the first report to demonstrate that conditional specific inactivation of one gene in the endothelium impacts global intestinal response following radiation injury.
PAI-1 is an anti-fibrinolytic and pro-fibrotic protein7. Here, we show that irradiation very rapidly induces fibrin deposition. Surprisingly, PAI-1 deletion in endothelium does not affect fibrin deposition, suggesting that PAI-1 contributes to intestinal injury independently of its anti-fibrinolytic action, or that another cellular pool of PAI-1 is involved.
Crosstalk between thrombosis and inflammation is an emerging concept explaining tissue homeostasis following stress or a wound healing process26. Relationships between PAI-1 and the inflammatory process have already been described. PAI-1 knockout mice have a lower influx of neutrophils in a model of lung27 or renal28 injury. Moreover, PAI-1 inhibits neutrophil efferocytosis29 and limits spontaneous or TNF-related apoptosis-inducing ligand (TRAIL)-dependent neutrophil apoptosis30. In our present work, neutrophil influx was measured using MPO labeling. The results show that endothelial inactivation of PAI-1 does not affect the severity of intestinal neutrophil influx in the acute and late phases after irradiation. This result suggests that the endothelial PAI-1 radiation-induced overexpressed pool is not directly involved in neutrophil influx after irradiation. Fibrinolysis regulators are involved in adhesion of monocytes to endothelial cells in vitro. PAI-1 and uPA are required for GlyLDL-induced monocyte adhesion to endothelial cells31. Macrophages are highly heterogeneous cells that can adapt their functions in response to local microenvironmental signals.
In our work, gene expression profiles revealed that radiation exposure induces molecular alterations compatible with modification of macrophage polarization. TNFα but also IL6, IL10, Ccr7, Hmox1 and IL1-β have been described to be involved in M1 or M2 polarization and to be expressed by different macrophages subsets32. The protective and pathogenic functions of macrophage subsets in the fibrosis and wound healing processes after irradiation are unclear. Macrophage polarization is a mechanism that is dependent on context, such as both the tissue microenvironment and progression of the wound healing process33. M1 macrophages are considered as pro-inflammatory immune cells which can exacerbate the inflammatory response by recruiting T helper type 17 lymphocytes and neutrophils, leading to persistent pro-inflammatory signals and substantial tissue damage. In contrast to the pro-inflammatory response triggered by M1 macrophages, M2 macrophages exhibit mainly anti-inflammatory actions. M2 macrophages antagonize the response of M1 macrophages, which may be crucial for the activation of the wound healing process and for restoration of tissue homeostasis. We showed that conditional endothelium-specific PAI-1 deletion limits radiation-induced macrophage infiltration (CD68+ cells) in the radiation acute phase. Levels of M1-type cell influx were also reduced in PAI-1KOendo in the acute and late phases. Although a reduced number of M2-type cells was observed at day 3 after irradiation, a higher number was observed in the late phase in PAI-1KOendo mice compared with floxed irradiated mice. Interestingly, this increase is associated with reduced tissue injury. Further experiments are needed to explore the putative causal links between these two observations and to indicate if macrophages polarization impacts the progression of radiation-induced intestinal injury.
In this work we used VE-cadherin Cre-recombinase mice and showed that PAI-1 deletion in PAI-1KOendo mice impacts immune cell influx. The origin of these immune cells is unknown but a myeloid contribution is probable. Using VEcad-Cre-ROSA26R mice, Alva et al. showed that about 50% of all hematopoietic lineages were positive for LacZ in the adult bone marrow34. Therefore, we cannot exclude that protection from radiation injury associated with PAI-1 deletion using VEcad-Cre could be due, at least in part, to recombination events in the bone marrow, leading to PAI-1 genetic inactivation in some myeloid progenitors. Interestingly, using VECad-CreERT2−ROSA26R mice, Monvoisin et al. reported only 0.3% of LacZ+ cells in the bone marrow of adult mice, showing that recombination events in myeloid progenitors are minor events in this model35. We confirmed protection from radiation-induced intestinal injury using PAI-1KOendo inducible mice created by crossing VECad-Cre-ERT2 tamoxifen inducible Cre mice with PAI-1fl/fl mice. These results confirm that specific PAI-1 endothelial deletion conferred protection against radiation enteritis.
Bioinformatic tools are useful in exploring and analyzing large amounts of data. Here, we measured about one hundred genes in 3 groups of mice at several time points after irradiation, representing thousands of real-time PCR data. We used a pathway analysis tool to explain in detail the differences between mice according their PAI-1 expression in the endothelium. GO enrichment analyses revealed possible differences between mice linked to the response to the hypoxia pathway. Hypoxia response elements are present in the PAI-1 gene promoter and the transcription factor HIF-1α has been shown to be involved in PAI-1-dependent transcription in vitro36. We therefore hypothesized that HIF-1α could be involved in the radiation-induced PAI-1 up-regulation. Using VECad-Cre+/−/HIF-1αflx/flx, we have shown here that PAI-1 overexpression is at least in part dependent on HIF-1α expression in endothelium. These results suggest that a hypoxia-PAI-1 axis could be crucial in the progression of radiation-induced enteritis through the endothelium compartment. The detailed mechanisms are not yet fully understood and further experiments are needed to explore them.
In conclusion, we demonstrate in this work that PAI-1 plays a role in the initiation of radiation-induced intestinal injury by an endothelium-dependent mechanism. The endothelial pool of PAI-1 directly or indirectly influences the in vivo inflammatory process by affecting recruitment and polarization of macrophages. Our study confirms that PAI-1 is an attractive therapeutic target in attempts to reduce radiation-induced normal tissue injury. We previously tested the PAI-1 inhibitor tiplaxtinin, which had a small beneficial effect by conferring temporary protection against early lethality37. Tiplaxtinin inhibits free PAI-1, but not the vitronectin-bound pool of PAI-138, thus limiting de facto the efficacy of this PAI-1 inhibitor. New PAI-1 inhibitors have been described39,40,41 recently and should be tested in the light of our results. More conceptually, this work supports the concept that a modification of endothelium phenotype affects the progression of radiation-induced radiation enteritis.
Materials and Methods
Generation of PAI-1 floxed mice and animals
The global molecular strategy for creating PAI-1 floxed mice is summarized in Fig. 1. The targeting vector was created from SERPINE1/PAI-1 genomic sequences, which were isolated by PCR amplification of genomic DNA. This vector was linearized by restriction digestion with Fse I, electroporated into 129/Sv ES cells and the transformed cells were subjected to G418 selection. Of 322 G418-resistant ES cell clones, homologous recombination was confirmed in 6 by both Southern blot analysis using 2 different probes outside the region of homology and PCR analysis with N1 and N2 primers (Supplementary Fig. 1). Three of these clones were used to generate chimeras by standard procedures. Germline transmission was obtained by crossing the chimeras with C57BL/6J females. Heterozygous females were crossed with CMV-Flp males to excise the neomycin selection cassette. When excision of the neomycin selection cassette was successful, a 547-bp PCR product was amplified, using primers P2 and P4 from the genomic tail DNA of the offspring (Fig. 1). Homozygous floxed mice were finally obtained by interbreeding F2 heterozygous floxed mice. The following mice were used for this study: VE-cadherin-Cre (VECad-Cre) mice34, VE-cadherin-Cre-ERT2 (VECad-Crei) mice35, ROSA26R LacZ reporter (ROSA) mice (Jackson Laboratory), HIF-1α floxed mice (HIF-1αflx/flx) (Jackson Laboratory) and PAI-1 floxed (PAI-1flx/flx) mice. Crossing of these lines was used to obtain the following mice: VECad-Cre+/−/ROSA+/+, VECad-Crei +/−/ROSA+/+, VECad-Cre+/−/HIF-1αflx/flx, VECad-Cre+/−/PAI-1flx/flx (PAI-1KOendo) and VECad-Crei+/−/PAI-1flx/flx (PAI-1KOendo(i)) mice.
Genotyping of mice
Genomic tail DNA was analyzed by PCR. For genotyping wild-type, targeted and recombined PAI-1 alleles, 3 primers were used: P1: 5′-CCATGTGGGGAGTCAGACATGCTTC-3′ forward; P2: 5′-CAGCCATCACAGAGAAGCTATGGACC-3′ reverse; P3: 5′-CCAGGCAGATGAGGCTCTTCCAATC-3′ reverse. P1 and P2 detect the wild-type endogenous allele (255 bp) and the floxed allele (370 bp), whereas P1 and P3 detect Cre-excised allele (690 bp) (Fig. 1A). For detection of full excision neomycin cassette alleles, two primers were used: P2 and P4: 5′-GCTGTACTGGTTCTTGCTCCTTGACAGA-3′ forward. A 547-bp PCR product was detected with P1 and P4 when the Flp-mediated excised allele occurred (Fig. 1A). Presence or absence of Cre recombinase was assayed with 3 primers: C1: 5′- GCAGGCAGCTCACAAAGGAACAAT-3′ forward, C2: 5′-TGTCCTTGCTGAGTGACAGTGGAA-3′ reverse, C3: 5′-ATCACTCGTTGCATCGACCGGTAA-3′ reverse. C1 and C2 detect the endogenous VE-cadherin locus (therefore absence of Cre) (550 bp), whereas C1 and C3 detect VE-cadherin-Cre recombinase (310 bp). Presence or absence of the ROSA26 fragment was assayed with three primers: R1: 5′-AAAGTCGCTCTGAGTTGTTAT -3′ forward, R2: 5′-GCGAAGAGTTTGTCCTCAACC-3′ reverse, R3: 5′-GGAGCGGGAGAAATGGATATG -3′ reverse. R1 and R2 detected the ROSA26 fragment (603 bp), whereas R1 and R3 detected the endogenous locus (therefore absence of ROSA26 fragment) (340 bp).
Experimental procedures
Experiments were conducted in compliance with legal regulations in France for animal experimentation and protocols were approved by the national ethics committee for animal experimentation of the Institute for Radiological Protection and Nuclear Safety no. 81 (Protocol 13–18). Radiation enteropathy was induced by exposure of an intestinal segment to 19 Gy of radiation as previously described13. Briefly, control PAI-1flx/flx mice and PAI-1KOendo mice were anesthetized with isoflurane and, after laparotomy, a 3 cm-long intestinal segment (10 cm from the ileocecal valve) was exteriorized and exposed to a single dose of 19 Gy of gamma irradiation (60Co source, dose rate 0.8 Gy/minute). Sham-irradiation (Sham-IR) was performed by maintaining the intestinal segment exteriorized without radiation exposure. After radiation exposure or sham-irradiation, the exposed segment was returned to the abdominal cavity and peritoneum/abdominal muscles and skin were separately closed with interrupted sutures. Each animal was used for all experiments described below. Activation of CreERT2 recombinase was induced by daily intraperitoneal injections of 2 mg tamoxifen (diluted in 10% EtOH in sunflower oil) for 5 days35. Irradiations occurred one week after the first injection, a time point at which we checked that CreERT2 recombinase was functional.
Histology and immunohistochemistry
A part of the intestinal segment was assessed by histological examination and immunohistochemistry. Longitudinal pieces were fixed in 4% formaldehyde solution and embedded in paraffin. 5 μm sections were stained with hematoxylin-eosin-saffron and Sirius red. For β-Gal staining, a part of the intestinal tissues was embedded with Tissue-Tek OCT mounting media and frozen in isopentane cooled by liquid nitrogen. Assays were performed on 16 μm frozen sections, using the β-Gal staining kit (Invitrogen) according to the manufacturer’s instructions. Slides were then counterstained with nuclear fast red (Sigma) according to the manufacturer’s instructions. We used the following primary antibodies for immunohistochemistry: rabbit anti-human von Willebrand factor from DAKO, rabbit anti-human fibrinogen from DAKO, rabbit anti-mouse MPO from Abcam, rabbit anti-mouse CD68 from Abcam, rabbit anti-mouse CD206 from Abcam, rabbit anti-mouse iNOS from Abcam and anti-rat E-cadherin (Clone ECDD2) from Life Technology. Goat anti-rabbit Alexa fluor568, goat anti-rat Alexa fluor568 and goat anti-rabbit Alexa fluor488(Molecular Probes) were used as secondary antibodies for immunofluorescent labeling. ImmPress Reagent anti-rabbit Ig (Vector Labs) and Histogreen (Abcys) were used for visible IHC labels.
For fluorescent labeling, all images were recorded using a Zeiss LSM 780 confocal microscope. For E-cadherin/TUNEL double staining, TUNEL staining was performed using the In Situ Cell Death Detection Kit (Roche Applied Science) according to the manufacturer’s instructions. Epithelial cells and apoptotic epithelial cells were counted in about 60 crypt sections per sample from the same animals.
Semi-quantitative fibrin deposition score was determined by two authors in a blinded manner and ranged from 0 (no deposition) to 4 (strong deposition). Discrepancies were resolved by discussion.
For immune cell staining (CD68 and MPO), scoring was determined according to the number of cells present in the tissue. Following a first reading, a score was attributed to each animal, ranging from 0 (sham-IR mice) to 4 (maximum number of observed cells) or 2 (minimum number of observed cells). Score was determined in a blinded manner.
M1 type macrophages (CD68+/iNOS+) were quantified as follows. For each mouse, three images were recorded using a Zeiss LSM 780 confocal microscope and double-labeled cells were counted. For each image, the length of intestine was determined and the results were presented as the number of (CD68+/iNOS+)/length unit (here 1000 μm).
M2 type macrophages (CD68+/CD206+) were quantified as follows. For each mouse, three images were recorded using a Zeiss LSM 780 confocal microscope and for each color (red for CD68 or green for CD206) a threshold was determined and fixed. Images were processed using Zen software for automatic quantification of the pixel number of each color or both of them. Results were presented as relative quantification of M2 type macrophages, which represent the ratio between the number of pixels with the two colors and the number of pixels corresponding only to the red (CD68).
RNA isolation, reverse transcription, real-time qPCR, TLDA and data analysis. Total RNA was prepared with the total RNA isolation kit (Rneasy Mini Kit; Qiagen). After quantification on a NanoDrop ND-1000 apparatus (NanoDrop Technologies), 1 μg of RNA was used for reverse transcription with the High Capacity Reverse Transcription Kit (Applied Biosystems) according to the manufacturer’s instructions. Pre-developed TaqMan Gene Expression Assays and TaqMan Mouse Immune Array (Applied Biosystems) were used according to the manufacturer’s instructions. PCR was performed with the ABI PRISM 7900 Sequence detection system (Applied Biosystems). PCR fluorescent signals were normalized to a PCR fluorescent signal obtained from the housekeeping gene 18S. Relative mRNA quantification was performed by using the comparative ΔΔCT method. For each time point, analyses were conducted according to the following procedure. Ct values were extracted from a global analysis using RQ Manager software (Applied Biosytems) in order to apply and normalize optimal baselines and threshold parameters for each target. A text file was extracted and Ct values were imported in Data Assist software (v3.01) in which each mouse was annotated according to its group (Sham-IR, Irradiated Floxed or irradiated PAI-1 KOendo mice). For determining expression fold changes, a maximum allowable Ct value at 37 was fixed and maximum Ct values were not included in calculations. For all analyses, the reference sample group was the Sham-IR group, automatically leading the mean of the reference group to the value 1. The Ct values were normalized using a global normalization method: the software first finds the common assays among all samples and then used the median CT of those assays as the normalizer, on a per sample basis42. p-values were adjusted using the Benjamini-Hochberg false discovery rate (FDR) method. Volcano plots were created and used to select the differentially expressed genes using a fold change cut-off of 1.5 and adjusted p-values < 0.05. For unsupervised hierarchical clustering analyses and heat map creation, distances between samples were calculated for hierarchical clustering based on the ΔCT values using Pearson’s correlation, assay centric as map type and average linkage as clustering method. For each assay, the middle expression level is set as the median of all of the ΔCT values from all samples for that assay. Data points for a given assay can only be compared relative to other data points for that assay. For each map type, the ΔCT value of the neutral/middle expression level (median) is set such that red indicates an increase with a ΔCT value below the middle level and green indicates a decrease, with a ΔCT value above the middle level. Pathway Studio 10.0 along with ResNet 11.0 from Elsevier, the database of functional relationships and pathways of mammalian proteins (www.elsevier.com/pathway-studio), was used for pathway analysis and gene ontology enrichments.
Statistical analysis
Data are given as means +/− SEM. Statistical analyses were performed by analysis of variance with a level of significance of p < 0.05. Mouse survival curves were calculated by the Kaplan Meier method and compared using the log rank test.
Additional Information
How to cite this article: Rannou, E. et al. In vivo evidence for an endothelium-dependent mechanism in radiation-induced normal tissue injury. Sci. Rep. 5, 15738; doi: 10.1038/srep15738 (2015).
References
Bentzen, S. M. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 6, 702–713 (2006).
Andreyev, H. J., Wotherspoon, A., Denham, J. W. & Hauer-Jensen, M. Defining pelvic-radiation disease for the survivorship era. Lancet Oncol 11, 310–312 (2010).
Hauer-Jensen, M., Denham, J. W. & Andreyev, H. J. Radiation enteropathy—pathogenesis, treatment and prevention. Nat Rev Gastroenterol Hepatol 11, 470–479 (2014).
Atwood, K. C. & Norman, A. On the Interpretation of Multi-Hit Survival Curves. Proc Natl Acad Sci USA 35, 696–709 (1949).
Baker, D. G. & Krochak, R. J. The response of the microvascular system to radiation: a review. Cancer Invest 7, 287–294 (1989).
Wang, J., Boerma, M., Fu, Q. & Hauer-Jensen, M. Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy. World J Gastroenterol 13, 3047–3055 (2007).
Kohler, H. P. & Grant, P. J. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 342, 1792–1801 (2000).
Renckens, R. et al. The role of plasminogen activator inhibitor type 1 in the inflammatory response to local tissue injury. J Thromb Haemost 3, 1018–1025 (2005).
Bauman, K. A. et al. The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice. J Clin Invest 120, 1950–1960 (2010).
Oda, T. et al. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int 60, 587–596 (2001).
Osterholzer, J. J. et al. PAI-1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injury. J Pathol 228, 170–180 (2012).
Halle, M., Ekstrom, M., Farnebo, F. & Tornvall, P. Endothelial activation with prothrombotic response in irradiated microvascular recipient veins. J Plast Reconstr Aesthet Surg 63, 1910–1916 (2010).
Milliat, F. et al. Essential role of plasminogen activator inhibitor type-1 in radiation enteropathy. Am J Pathol 172, 691–701 (2008).
Ebrahimian, T. G. et al. Plasminogen activator inhibitor-1 controls bone marrow-derived cells therapeutic effect through MMP9 signaling: role in physiological and pathological wound healing. Stem Cells 30, 1436–1446 (2012).
Qiu, W. et al. PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell 2, 576–583 (2008).
Zheng, H., Wang, J., Koteliansky, V. E., Gotwals, P. J. & Hauer-Jensen, M. Recombinant soluble transforming growth factor beta type II receptor ameliorates radiation enteropathy in mice. Gastroenterology 119, 1286–1296 (2000).
Cho, C. H. et al. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci USA 101, 5547–5552 (2004).
Paris, F. et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293, 293–297 (2001).
Rotolo, J. et al. Anti-ceramide antibody prevents the radiation gastrointestinal syndrome in mice. J Clin Invest 122, 1786–1790 (2012).
Schuller, B. W. et al. No significant endothelial apoptosis in the radiation-induced gastrointestinal syndrome. Int J Radiat Oncol Biol Phys 68, 205–210 (2007).
Schuller, B. W. et al. Selective irradiation of the vascular endothelium has no effect on the survival of murine intestinal crypt stem cells. Proc Natl Acad Sci USA 103, 3787–3792 (2006).
Kim, D. W. et al. Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 89, 509–517 (2014).
Kirsch, D. G. Using genetically engineered mice for radiation research. Radiat Res 176, 275–279 (2011).
Lee, C. L. et al. p53 functions in endothelial cells to prevent radiation-induced myocardial injury in mice. Sci Signal 5, ra52 (2012).
Kirsch, D. G. et al. p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis. Science 327, 593–596 (2010).
Engelmann, B. & Massberg, S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 13, 34–45 (2013).
Wolthuis, E. K. et al. Plasminogen activator inhibitor-type I gene deficient mice show reduced influx of neutrophils in ventilator-induced lung injury. Crit Care Res Pract 2011, 217896 (2011).
Roelofs, J. J. et al. Plasminogen activator inhibitor-1 regulates neutrophil influx during acute pyelonephritis. Kidney Int 75, 52–59 (2009).
Park, Y. J. et al. PAI-1 inhibits neutrophil efferocytosis. Proc Natl Acad Sci USA 105, 11784–11789 (2008).
Zmijewski, J. W. et al. Inhibition of neutrophil apoptosis by PAI-1. Am J Physiol Lung Cell Mol Physiol 301, L247–254 (2011).
Zhao, R., Ren, S., Moghadasain, M. H., Rempel, J. D. & Shen, G. X. Involvement of fibrinolytic regulators in adhesion of monocytes to vascular endothelial cells induced by glycated LDL and to aorta from diabetic mice. J Leukoc Biol 95, 941–949 (2014).
Chinetti-Gbaguidi, G., Colin, S. & Staels, B. Macrophage subsets in atherosclerosis. Nat Rev Cardiol 12, 10–17 (2015).
Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11, 723–737 (2011).
Alva, J. A. et al. VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev Dyn 235, 759–767 (2006).
Monvoisin, A. et al. VE-cadherin-CreERT2 transgenic mouse: a model for inducible recombination in the endothelium. Dev Dyn 235, 3413–3422 (2006).
Fink, T., Kazlauskas, A., Poellinger, L., Ebbesen, P. & Zachar, V. Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1. Blood 99, 2077–2083 (2002).
Abderrahmani, R. et al. Effects of pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 in radiation-induced intestinal injury. Int J Radiat Oncol Biol Phys 74, 942–948 (2009).
Gorlatova, N. V. et al. Mechanism of inactivation of plasminogen activator inhibitor-1 by a small molecule inhibitor. J Biol Chem 282, 9288–9296 (2007).
Boe, A. E. et al. Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nomega-nitro-L-arginine methyl ester-induced hypertension and vascular senescence. Circulation 128, 2318–2324 (2013).
Florova, G. et al. Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits. Am J Respir Cell Mol Biol 52, 429–437 (2015).
Ibrahim, A. A. et al. Inhibition of plasminogen activator inhibitor type-1 activity enhances rapid and sustainable hematopoietic regeneration. Stem Cells 32, 946–958 (2014).
Mestdagh, P. et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10, R64 (2009).
Acknowledgements
We thank the GSEA (Groupe de Soutien à l’Experimentation Animale) of the IRSN for their excellent technical assistance with the breeding of mice and Genoway for expertise and collaboration in the design of PAI-1 floxed mice. Grant support: This work was supported by Electricité de France EDF (Groupe Gestion Projet Radioprotection) and the Institute for Radiological Protection and Nuclear Safety (ROSIRIS program).
Author information
Authors and Affiliations
Contributions
E.R. performed experiments and interpreted the results; helped write the manuscript, critical review of the manuscript. A.F. performed experiments, interpreted the results and critical review of the manuscript. A.T., V.B., G.T., E.M. and C.J. performed experiments. O.G., M.B. and J.-C.S. critical review of the manuscript. M.L.I. material support and critical review of the manuscript. F.M. Conception and design of the work, writing of the manuscript, supervising the project.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Electronic supplementary material
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Rannou, E., François, A., Toullec, A. et al. In vivo evidence for an endothelium-dependent mechanism in radiation-induced normal tissue injury. Sci Rep 5, 15738 (2015). https://doi.org/10.1038/srep15738
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep15738
This article is cited by
-
Profiling mRNA, miRNA and lncRNA expression changes in endothelial cells in response to increasing doses of ionizing radiation
Scientific Reports (2022)
-
Fractionated radiation suppresses Kruppel-like factor 2 pathway to a greater extent than by single exposure to the same total dose
Scientific Reports (2020)
-
Variation of 4 MV X-ray dose rate strongly impacts biological response both in vitro and in vivo
Scientific Reports (2020)
-
Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy
Clinical and Translational Oncology (2020)
-
HMGB1-modified mesenchymal stem cells attenuate radiation-induced vascular injury possibly via their high motility and facilitation of endothelial differentiation
Stem Cell Research & Therapy (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.